EORTC-24872-HNCG

Randomized phase III trial of methotrexate vs 10-EdAm, a new methotrexate analogue,in patients with advanced squamous cell carcinoma of the head and neck
Trial StatusAll trial activities ended
DatesDate of activation: 15-Mar-88
Closed on : 19-Feb-92
Data management at EORTCFull
Phase2
Randomized trial
Type-
Targeted Sample size40
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT number
EudraCT